Connection

Rolando Cimaz to Biological Products

Back to Details
This is a "connection" page, showing publications Rolando Cimaz has written about Biological Products.
Rolando Cimaz
Connection Strength
1.202
Biological Products
  1. Patients with juvenile idiopathic arthritis on TNF inhibitors exposed to COVID-19 family members. Semin Arthritis Rheum. 2020 12; 50(6):1214-1215.
    View in: PubMed
    Score: 0.297
  2. One year in review: Kawasaki disease. Curr Opin Rheumatol. 2020 01; 32(1):15-20.
    View in: PubMed
    Score: 0.282
  3. Growth and body mass index in a cohort of patients with juvenile idiopathic arthritis: effects of second line treatments. Clin Exp Rheumatol. 2018 Sep-Oct; 36(5):929-933.
    View in: PubMed
    Score: 0.255
  4. Flares After Withdrawal of Biologic Therapies in Juvenile Idiopathic Arthritis: Clinical and Laboratory Correlates of Remission Duration. Arthritis Care Res (Hoboken). 2018 07; 70(7):1046-1051.
    View in: PubMed
    Score: 0.250
  5. Absence of Severe Complications From SARS-CoV-2 Infection in Children With Rheumatic Diseases Treated With Biologic Drugs. J Rheumatol. 2021 08; 48(8):1343-1344.
    View in: PubMed
    Score: 0.072
  6. Does switching anti-TNFa biologic agents represent an effective option in childhood chronic uveitis: the evidence from a systematic review and meta-analysis approach. Semin Arthritis Rheum. 2014 Aug; 44(1):39-46.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.